Johnson & Johnson (JNJ): A Dividend Aristocrat With Unmatched Stability

Johnson & Johnson (NYSE:JNJ) is included among the 10 Best Recession Proof Dividend Stocks to Buy.

Johnson & Johnson (NYSE:JNJ), founded in 1886 to produce sterile surgical supplies after the Civil War, has since grown into one of the largest global pharmaceutical and medical device companies.

Unlike some drugmakers that rely heavily on a single blockbuster treatment, Johnson & Johnson (NYSE:JNJ) maintains a diverse portfolio across multiple areas, helping limit swings in its earnings once patents expire.

Although demand for medical devices can dip during recessions when elective procedures are delayed, the steady need for many essential treatments helps support the company’s stability. Backed by a long record of paying dividends, Johnson & Johnson (NYSE:JNJ) is well-positioned to remain a key player for decades, regardless of downturns or bear markets.

Johnson & Johnson (NYSE:JNJ) has been increasing its dividends for 63 consecutive years, which makes it one of the best dividend stocks for a recession. The company offers a quarterly dividend of $1.30 per share and has a dividend yield of 2.89%, as of September 26.

While we acknowledge the potential of JNJ as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 11 Best Telecom Dividend Stocks to Buy for 2025 and 11 Best Bank Dividend Stocks to Buy.

Disclosure: None.